Joost S.P. Vermaat

3.2k citations
74 papers · 1.6k indexed · h-index 17

Joost S.P. Vermaat

64 papers receiving 1.6k citations

Peers

Joost S.P. Vermaat
Comparison fields: 5 of 87
  • Molecular Biology 743
  • Oncology 727
  • Cancer Research 500
  • Pathology and Forensic Medicine 412
  • Genetics 203
Replace Ellen Leich with:
Ellen Leich Germany
Katherine E. Hutchinson United States
Reimi Asaka Japan
Armelle Logié United Kingdom
Diana Mandelker United States
Nikita Makretsov Canada
Gregory R. Bean United States
Sara Cresta Italy
Hui‐Zi Chen United States
Subhadra V. Nandula United States
Joost S.P. Vermaat relative to Ellen Leich Germany Ellen Leich's profile →
Citations per field
00.5×1.5×1.8×
Ellen Leich · 1×
Citations per year

Countries citing papers authored by Joost S.P. Vermaat

Since Specialization
Citations

This map shows the geographic impact of Joost S.P. Vermaat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost S.P. Vermaat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost S.P. Vermaat more than expected).

Fields of papers citing papers by Joost S.P. Vermaat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost S.P. Vermaat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost S.P. Vermaat. The network helps show where Joost S.P. Vermaat may publish in the future.

Co-authorship network of co-authors of Joost S.P. Vermaat

This figure shows the co-authorship network connecting the top 25 collaborators of Joost S.P. Vermaat. A scholar is included among the top collaborators of Joost S.P. Vermaat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joost S.P. Vermaat. Joost S.P. Vermaat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 5
5 3
6 7
7 0
8 5
9 5
10 0
11 5
12 7
13 9
14 14
15 16
16 57
17 37
18 1
19 119
20 107

About Joost S.P. Vermaat

Joost S.P. Vermaat is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 74 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (18 papers) and CAR-T cell therapy research (18 papers). The work is most often cited by research in Cancer Research (500 citations), Oncology (727 citations) and Pathology and Forensic Medicine (412 citations). Joost S.P. Vermaat has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Emile E. Voest, Niven Mehra, Laurens V. Beerepoot, Bernard A. Zonnenberg, Jeanine M.L. Roodhart, P. J. van Diest, Rachel H. Giles, Patrick W.B. Derksen, Miranda van Amersfoort and Anne M.R. Schrader. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026